News Headlines

  1. CDMO LSNE Receives Approval To Manufacture Commercial Aseptic Generic Product At León, Spain Facility

    Lyophilization Services of New England (LSNE), a privately held contract and development manufacturing organization, announces approval of an Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (FDA), for a sterile injectable product manufactured at their aseptic fill finish facility in León, Spain.

  2. CMAB Biopharma And BJ Bioscience Establish An Exclusive Strategic Partnership

    CMAB Biopharma (Suzhou) Inc. ("CMAB"), a pure-play biologics CDMO and BJ Bioscience Inc. ("BJ Bioscience"), an innovative biopharmaceutical enterprise, recently announced a comprehensive strategic agreement for the development and manufacturing of a Bi-functional Antibody (BJ-005) as the first step in an exclusive collaboration.

  3. Edgewater Capital Partners To Acquire Haematologic Technologies

    Edgewater Capital Partners announced recently that they have entered into an agreement to acquire Haematologic Technologies Incorporated, a leading provider of biologic products and GMP compliant assay development and testing services to the biopharmaceutical industry.

  4. MilliporeSigma Becomes The First To Use Acoustic Technology For Cell Therapy Manufacturing

    MilliporeSigma recently announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Financial details were not disclosed.

  5. MabPlex Lauded By Frost & Sullivan For Global Expansion Of ADC Contract Manufacturing Services

    Based on its recent analysis of the global antibody drug conjugate (ADC) contract manufacturing services market, Frost & Sullivan recognizes China-based MabPlex International, Ltd (MabPlex) with the 2019 Global Growth Excellence Leadership Award.

  6. CDMO Avid Bioservices Completes Expansion Of Laboratories At California Campus

    Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced the completion of the expansion of the company’s process development capabilities and laboratory space within its CDMO campus in Orange County, California.

  7. Alcami Launches New Rapid Sterility Testing Services

    Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biologics industries, today announced the launch of its new rapid sterility offering, a service that leverages cutting-edge microbiological testing technology to deliver significantly faster testing results to clients

  8. ACG Inspection To Open ‘Centre Of Excellence’ In Switzerland

    ACG Inspection, a division of ACG – the world’s only integrated pharmaceutical manufacturing and packaging solutions company - is to open a new ‘Centre of Excellence’ in Switzerland, supporting the company’s continued global expansion.

  9. Gerresheimer Opens Glass Innovation And Technology Center In The U.S.

    Gerresheimer is driving innovation in pharmaceutical glass, primary packaging glass products, technologies and digitized processes.

  10. Frontage Expands Bioanalytical Capacity And Capabilities To Support Biologic Drug Development, Biomarkers And Cell And Gene Therapy

    Frontage Laboratories, Inc., a contract research organization (“CRO”) providing integrated, science-driven, product development services, is pleased to announce the expansion of their bioanalytical laboratories.